This isn’t NowRx’s most recent raise. NowRx Preferred Equity 1 (Closed) is more current.View latest round
via SeedInvest · last checked Aug 17, 2026
Raised
$200K / $1M max
20% of ceiling
Investors
—
—
Valuation cap
$6M
cap, not an agreed valuation
Financials disclosed in this offering
FY2015–FY2016 · hover for source$0
−$247K
FY2015
$669K
−$663K
FY2016
RevenueNet income
Metric
FY2015
FY2016
Income statement
Revenue
$0
$668,695
Cost of goods sold
$0
$573,791
Gross margin
—
14%
Net income
-$247,240
-$662,535
Taxes paid
$0
$0
Balance sheet
Cash
$160,765
$175,519
Accounts receivable
$12,826
$128,552
Total assets
$308,161
$459,485
Short-term debt
$109,551
$210,910
Long-term debt
$445,000
$1,117,500
Total liabilities
$554,551
$2,188,261
Other
Headcount
—
12
The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.
Deal terms
Valuation cap$6M
Conversion discount20%
Offering details
Target$100,000
Max$1,000,000
Min investment—
OpenedApr 4, 2017
DeadlineJun 2, 2017
ClosedJun 2, 2017
Days active59
Links & provenance
Source: SEC EDGAR
0001644600-17-000040
Last synced Aug 17, 2026
0001644600-17-000040
Last synced Aug 17, 2026
About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.